COMMUNIQUÉS West-GlobeNewswire

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment

18/12/2024 - 19:30

MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]

Theratechnologies soumet un supplément d'approbation préalable à la FDA pour l’environnement de la fabrication d’EGRIFTA SV(MD)

18/12/2024 - 19:30

MONTRÉAL, 18 déc. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point et la commercialisation de [...]

KFSHRC Successfully Performs Robotic-Assisted Retroperitoneal Lymph Node Dissection

18/12/2024 - 19:03

RIYADH, Saudia Arabia, Dec. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has achieved a groundbreaking medical milestone in the Middle East by successfully [...]

Spineway wins new approvals in Vietnam and registers initial orders

18/12/2024 - 18:00

Press release Ecully, December 18, 2024 – 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, [...]

SPINEWAY obtient de nouvelles homologations au Vietnam et enregistre des premières commandes

18/12/2024 - 18:00

Communiqué de presse Ecully, le 18 décembre 2024 – 18h Spineway obtient de nouvelles homologations au Vietnam et enregistre des premières commandes Le groupe Spineway, spécialiste des implants innovants pour le [...]

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

18/12/2024 - 18:00

A clinical abstract on the induction results from the CoTikiS Phase 2 trial of anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral abstracts for 20 [...]

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO

18/12/2024 - 18:00

Un abstract clinique sur les résultats d’induction de l’étude de Phase 2 CoTikiS évaluant l’anti-IL-7 récepteur Lusvertikimab dans la rectocolite hémorragique a été accepté pour présentation orale et a été sélectionné [...]

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

18/12/2024 - 17:00

DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]

Public Mental Health Plans Sue State Over Broken Negotiations

18/12/2024 - 16:23

Legal Action Seeks to Protect Services and Secure Fair Contract Terms LANSING, Mich., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Michigan’s public mental health plans, known as Prepaid Inpatient Health Plans (PIHPs), have filed [...]

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases

18/12/2024 - 16:05

TigaTx will use the ARPA-H and NIH funding to progress its lead program, TIGA-001, an IgA anti-EGFR neutrophil engager, into the clinic and generate clinical proof-of-concept data for its engineered IgA platform TigaTx [...]

Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee

18/12/2024 - 16:05

The first location will serve as a new production facility for the company, tripling current production capacity ORLANDO, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leading innovator in the [...]

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

18/12/2024 - 16:00

ORION CORPORATION PRESS RELEASE 18 DECEMBER 2024 at 17.00 EET Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics Orion Corporation [...]

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting

18/12/2024 - 15:45

Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancer NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical [...]

The Hemp Doctor Expands With Third Store Location in Huntersville, NC

18/12/2024 - 15:21

MOORESVILLE, N.C., Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Hemp Doctor, an online and physical store retailer of hemp-derived products in the US, opens its third store location in Northlake Mall, 9548 Mt. Holly- [...]

HWH International Inc. Provides Updates on Travel Joint Venture

18/12/2024 - 15:20

BETHESDA, MD, Dec. 18, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to provide an update on the progress of a joint venture in its Hapi Travel business, in which HWH [...]

Healthcare Integrated Technologies welcomes Katie Piperata as Consultant for its Healthcare Division

18/12/2024 - 15:15

Knoxville, TN, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the engagement of Katie Piperata as a [...]

Longeveron to Present at Biotech Showcase 2025

18/12/2024 - 15:10

MIAMI, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Braille Institute Library to Host Livestream Event with Pulitzer Prize Finalist Andrew Leland on January 16, 2025

18/12/2024 - 15:00

Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Braille Institute Library is excited to announce a special event [...]

BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions

18/12/2024 - 15:00

Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to identify drug targets to treat diseases related to aging Novartis to [...]